» Articles » PMID: 12009578

Nitric Oxide As a Regulatory and Effector Molecule in the Immune System

Overview
Journal Mol Immunol
Date 2002 May 16
PMID 12009578
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Nitric oxide (NO) as a small ubiquitous molecule influencing a great variety of biological processes in the organism. Within the immune system, increased levels of NO were observed in various immunopathological situations, inflammatory reactions and during the response to transplantation and tumour antigens. It appears that NO can influence various facets of immune response. We studied involvement and the role of NO in immune response to skin allograft in mice. The production of NO at the site of graft rejection correlated well with the kinetic of rejection reaction and with the fate of the allograft. Graft infiltrating macrophages were identified as a principal cell population producing NO and the production of NO by macrophages was dependent on the presence of activated CD4(+) T cells. Survival of skin allografts was significantly prolonged by the treatment of graft recipients with 2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine (AMT), a specific inhibitor of inducible NO synthase (iNOS). These results suggest a role for NO as the effector cytotoxic molecule involved in the graft rejection. Experiments in vitro demonstrated that NO, in addition to its effector function, acts as a modulator of cytokine production. Spleen cells stimulated with alloantigens in the presence of AMT or S-ethylisothiourea (EIT), an another selective iNOS inhibitor, produced considerably more interleukin (IL)-4 and IL-10 than the cells stimulated in the absence of iNOS inhibitors. The production of Th1 cytokines IL-2 and interferon (IFN)-gamma was not enhanced by the inhibition of NO synthesis. The results altogether show that NO can act in transplantation reactions as an immunomodulator on cytokine production level and as an effector molecule involved in the graft destruction.

Citing Articles

Regulatory Role of Nitric Oxide in Cutaneous Inflammation.

Man M, Wakefield J, Mauro T, Elias P Inflammation. 2022; 45(3):949-964.

PMID: 35094214 PMC: 11249049. DOI: 10.1007/s10753-021-01615-8.


Nitric Oxide Participates in the Brain Ischemic Tolerance Induced by Intermittent Hypobaric Hypoxia in the Hippocampal CA1 Subfield in Rats.

Huang Y, Yuan Y, Liu Y, Zhang M, Zhang J, Wang T Neurochem Res. 2018; 43(9):1779-1790.

PMID: 29995175 DOI: 10.1007/s11064-018-2593-9.


Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent.

Sukhatme V, Bouche G, Meheus L, Sukhatme V, Pantziarka P Ecancermedicalscience. 2015; 9:568.

PMID: 26435741 PMC: 4583240. DOI: 10.3332/ecancer.2015.568.


Immunotoxicity of zinc oxide nanoparticles with different size and electrostatic charge.

Kim C, Nguyen H, Ignacio R, Kim J, Cho H, Maeng E Int J Nanomedicine. 2015; 9 Suppl 2:195-205.

PMID: 25565837 PMC: 4279726. DOI: 10.2147/IJN.S57935.


Modulation of the early inflammatory microenvironment in the alkali-burned eye by systemically administered interferon-γ-treated mesenchymal stromal cells.

Javorkova E, Trosan P, Zajicova A, Krulova M, Hajkova M, Holan V Stem Cells Dev. 2014; 23(20):2490-500.

PMID: 24849741 PMC: 4186059. DOI: 10.1089/scd.2013.0568.